Endocannabinoid System-Mediated Mechanisms of Acupuncture for Pain, Pruritus and Comorbid Neuropsychiatric Symptoms: A Systematic Review
DOI:
https://doi.org/10.54097/w8vbx312Keywords:
Acupuncture, Endocannabinoid system, Pain, pruritus and neuropsychiatric disorders, Cell-type-specific mechanism.Abstract
In chronic pain, pruritus, anxiety, and depression—highly comorbid neurological disorders characterized by neuroinflammation, central sensitization, and circuit dysfunction—the endocannabinoid system (ECS, comprising CB1/CB2/GPR55 receptors, endogenous ligands AEA/2-AG, and metabolic enzymes FAAH/MAGL) serves as a key regulatory hub modulating inflammatory processes, synaptic plasticity, and neuronal homeostasis. Here, we present a systematic review of preclinical studies from the past three years (2023–2026), integrating multi-level evidence of ECS-mediated acupuncture for the above disorders. Preclinical evidence has established that acupuncture precisely modulates the ECS at peripheral (activating fibroblast CB2R to inhibit mast cell degranulation and inflammatory cytokines; upregulating sensory neuronal CB1R to suppress Nav1.8/COX-2 pathways), spinal (CB2R promoting microglial M2 polarization to alleviate neuroinflammation; CB1R inhibiting glial TLR4/MyD88/TRAF6 cascades), and supraspinal levels (cell-type-specific CB1R in vlPAG/RVM/ACC bidirectionally regulating pain and itch; hippocampal CB2R/AEA and GPR55 pathways mediating antidepressant and anxiolytic effects). Notably, the ECS exhibits dynamic compensatory crosstalk with the opioid system—when TRPM8 is deleted, analgesia shifts to exclusive ECS reliance; moreover, the hypothalamic OX1R-CB1R pathway activated by PC6 (Neiguan) stimulation provides an opioid-independent, tolerance-free analgesic strategy. Current challenges include lack of standardized acupuncture parameters, species differences, and insufficient clinical translational evidence. This review synthesizes molecular, cellular, and circuit-level evidence to support the ECS as a core integrative target for acupuncture in pain, pruritus, anxiety, and depression, and calls for advancing standardized acupuncture regimens and clinical translation of ECS-targeted therapies.
Downloads
References
[1] Pham, D.T., et al., TRPM8's Role in the Shift Between Opioid and Cannabinoid Pathways in Electroacupuncture for Inflammatory Pain in Mice. Int J Mol Sci, 2024. 25(23): p. 13000. DOI: https://doi.org/10.3390/ijms252313000
[2] Lee, M.T., et al., Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice. J Pain, 2021. 22(3): p. 300–312. DOI: https://doi.org/10.1016/j.jpain.2020.09.003
[3] Wu, J., et al., Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain. Mol Neurobiol, 2024. 61(5): p. 2949–2963. DOI: https://doi.org/10.1007/s12035-023-03760-7
[4] Shen, S.Y., et al., The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice. Neurobiol Dis, 2022. 169: p. 105743. DOI: https://doi.org/10.1016/j.nbd.2022.105743
[5] Tu, S.W., et al., Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis. Front Immunol, 2026. 17: p. 1715313. DOI: https://doi.org/10.3389/fimmu.2026.1715313
[6] Ge, W., et al., Electroacupuncture exerts antipruritic and anti-inflammatory effects on atopic dermatitis by activating CB2 receptor. Chin Med, 2025. 20(1): p. 72. DOI: https://doi.org/10.1186/s13020-025-01102-4
[7] Ho, T.J., et al., Electroacupuncture attenuates inflammatory pain via peripheral cannabinoid receptor type 1 signaling pathway in mice. PLoS One, 2023. 18(12): p. e0295432. DOI: https://doi.org/10.1371/journal.pone.0295432
[8] Yuan, X.C., et al., Electroacupuncture Potentiates Cannabinoid Receptor-Mediated Descending Inhibitory Control in a Mouse Model of Knee Osteoarthritis. Front Mol Neurosci, 2018. 11: p. 112. DOI: https://doi.org/10.3389/fnmol.2018.00112
[9] Ge, W.Q., et al., Electroacupuncture reduces chronic itch via cannabinoid CB1 receptors in the ventrolateral periaqueductal gray. Front Pharmacol, 2022. 13: p. 931600. DOI: https://doi.org/10.3389/fphar.2022.931600
[10] Wan, K., et al., Electroacupuncture produces analgesic effects via cannabinoid CB1 receptor-mediated GABAergic neuronal inhibition in the rostral ventromedial medulla. Chin Med, 2025. 20(1): p. 30. DOI: https://doi.org/10.1186/s13020-025-01083-4
[11] Chen, X.R., et al., Cannabinoid type 2 receptors play a crucial role in social defeat-induced depression. J Affect Disord, 2024. 348: p. 333–344. DOI: https://doi.org/10.1016/j.jad.2023.12.089
[12] Chen, Y.H., et al., Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray. Proc Natl Acad Sci U S A, 2018. 115(45): p. E10720–e10729. DOI: https://doi.org/10.1073/pnas.1807991115
[13] Hsiao, I.H., et al., Electroacupuncture Relieves Fibromyalgia Pain in a Female Mouse Model by Augmenting Cannabinoid Receptor 1 Expression and Suppressing Astrocyte and Microglial Activation in Nociceptive Pathways. Biomedicines, 2025. 13(9): p. 2112. DOI: https://doi.org/10.3390/biomedicines13092112
[14] Liu, Y., et al., Transcriptomic Profiling in Mice with CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain. Front Pharmacol, 2021. 12: p. 781237. DOI: https://doi.org/10.3389/fphar.2021.781237
[15] Ma, N., et al., Electroacupuncture relieves visceral hypersensitivity through modulation of the endogenous cannabinoid system. Acupunct Med, 2023. 41(4): p. 224–234. DOI: https://doi.org/10.1177/09645284221107699
[16] Li, H., et al., Endocannabinoids regulate cocaine-associated memory through brain AEA-CB1R signalling activation. Mol Metab, 2022. 65: p. 101597. DOI: https://doi.org/10.1016/j.molmet.2022.101597
[17] Yuan, X.C., et al., Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis. J Pain Res, 2018. 11: p. 2797–2808. DOI: https://doi.org/10.2147/JPR.S171664
[18] Xia, F.Y., et al., [Effect of electroacupuncture on cannabinoid-related receptor CB2R and TRPV1 and spinal microglial polarization in rats with primary dysmenorrhea]. Zhen Ci Yan Jiu, 2025. 50(11): p. 1248–1256.
[19] Wang, Z., et al., Electroacupuncture inhibits mast cell degranulation via cannabinoid CB2 receptors in a rat model of allergic contact dermatitis. Acupunct Med, 2019. 37(6): p. 348–355. DOI: https://doi.org/10.1136/acupmed-2017-011506
[20] Zhang, H., et al., Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease. Front Pharmacol, 2022. 13: p. 861799. DOI: https://doi.org/10.3389/fphar.2022.861799
[21] Chen, T., et al., Electro-acupuncture Pretreatment at Zusanli (ST36) Acupoint Attenuates Lipopolysaccharide-Induced Inflammation in Rats by Inhibiting Ca(2+) Influx Associated with Cannabinoid CB2 Receptors. Inflammation, 2019. 42(1): p. 211–220. DOI: https://doi.org/10.1007/s10753-018-0885-5
[22] Zhang, H., et al., Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. Acupunct Med, 2016. 34(6): p. 463–470. DOI: https://doi.org/10.1136/acupmed-2016-011113
[23] Almeida, R.T., et al., Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats. Pharmacol Rep, 2016. 68(6): p. 1095–1101. DOI: https://doi.org/10.1016/j.pharep.2016.07.004
[24] Du, J., et al., CB2R Attenuates Intervertebral Disc Degeneration by Delaying Nucleus Pulposus Cell Senescence through AMPK/GSK3β Pathway. Aging Dis, 2022. 13(2): p. 552–567. DOI: https://doi.org/10.14336/AD.2021.1025
[25] Cheng, X., et al., CB2-mediated attenuation of nucleus pulposus degeneration via the amelioration of inflammation and oxidative stress in vivo and in vitro. Mol Med, 2021. 27(1): p. 92. DOI: https://doi.org/10.1186/s10020-021-00351-x
[26] Jiang, Z., et al., Combined-Acupoint Electroacupuncture Induces Better Analgesia via Activating the Endocannabinoid System in the Spinal Cord. Neural Plast, 2022. 2022: p. 7670629. DOI: https://doi.org/10.1155/2022/7670629
[27] Yeh, Y.A., et al., Electroacupuncture Regulates Cannabinoid Receptor 1 Expression in a Mouse Fibromyalgia Model: Pharmacological and Chemogenetic Modulation. Life (Basel), 2024. 14(11): p. 1499. DOI: https://doi.org/10.3390/life14111499
[28] Hsiao, I.H., et al., Chemogenetic Modulation of Electroacupuncture Analgesia in a Mouse Intermittent Cold Stress-Induced Fibromyalgia Model by Activating Cerebellum Cannabinoid Receptor 1 Expression and Signaling. Life (Basel), 2025. 15(9): p. 1458. DOI: https://doi.org/10.3390/life15091458
[29] Hu, X.F., et al., Electroacupuncture alleviates chronic stress-induced anxiety via excitatory neuron CB1 receptor-dependent suppression of GR/SGK1 signaling in the mPFC. J Affect Disord, 2026. 403: p. 121242. DOI: https://doi.org/10.1016/j.jad.2026.121242
[30] Hu, X.F., et al., Electroacupuncture Reduces Anxiety Associated with Inflammatory Bowel Disease by Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice. Front Pharmacol, 2022. 13: p. 919553. DOI: https://doi.org/10.3389/fphar.2022.919553
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

